SLC-0121

N/A

Report date: 2025/01/26 16:12:45
NME

Base Information

Drug NameSLC-0121
Drug Alias Namesecond-generation carbonic anhydrase-IX inhibitor (SignalChem Life Sciences)SLC-0121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrase IX inhibitors
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSignalchem Lifesciences
China Registration ClassN/A

Develop Information

Active CompaniesSignalchem Lifesciences
Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A